Evidence map›Paper›PMID 22732470›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2012

A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers.

Alyson B Moadel, Steven L Bernstein, Robin J Mermelstein, Julia H Arnsten, Eileen H Dolce, Jonathan Shuter

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02072772 (A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers), which is not on this map. Cited by 75 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02072772 nacompletednot on this mapstarted 2014, after this paper: background citation

A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers

TypeinterventionalSponsorMontefiore Medical CenterRan2014 to 2018Enrolled450ConditionsTobacco Use in Persons Living With HIVArmsPositively Smoke Free group treatment, Standard Care
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Interventions for tobacco use cessation in people living with HIV.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. What Are the Effective Components of Group-Based Treatment Programs For Smoking Cessation? A Systematic Review and Meta-Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Pooled it
  4. I am what I am: A meta-analysis of the association between substance user identities and substance use-related outcomes.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2021
    Pooled it
  5. Smoking cessation for improving mental health.The Cochrane database of systematic reviews · 2021
    Pooled it
  6. A Qualitative Systematic Review of Cigarette Smoking Cessation Interventions for Persons Living with HIV.Journal of cancer education : the official journal of the American Association for Cancer Education · 2019
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Group behaviour therapy programmes for smoking cessation.The Cochrane database of systematic reviews · 2017
    Pooled it
  11. Interventions for tobacco use cessation in people living with HIV and AIDS.The Cochrane database of systematic reviews · 2016
    Pooled it
  12. Pooled it
  13. Smoking-cessation interventions in people living with HIV infection: a systematic review.The Journal of the Association of Nurses in AIDS Care : JANAC
    Pooled it
  14. Trial
  15. Peer Navigation for Smoking Cessation in People With HIV Who Smoke: A Pilot Randomized Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  16. Trial
  17. The Role of Seed Users in Nurturing an Online Health Community for Smoking Cessation Among People With HIV/AIDS.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2024
    Trial
  18. Feasibility of a Smartphone-Based Tobacco Treatment for HIV-Infected Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  19. Trial
  20. Qualitative Exploration of a Smoking Cessation Trial for People Living With HIV in South Africa.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Trial

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alyson B MoadelDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Albert Einstein Cancer Center, Bronx, NY, USA.
Steven L Bernstein
Robin J Mermelstein
Julia H Arnsten
Eileen H Dolce
Jonathan Shuter

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected SmokersR21CA163100 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SHUTER, JONATHAN, STANTON, CASSANDRA A · 2011 to 2012
$410k
A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation InterventiR21DA023362 · NIDA · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SHUTER, JONATHAN · 2009 to 2010
$400k
NCI NIH HHS R21 CA163100NIAID NIH HHS AI-51519NIAID NIH HHS P30 AI051519NIDA NIH HHS R21 DA023362
6 · The paper itself

Abstract

backgroundMore than half of the persons living with human immunodeficiency virus (HIV; PLWH) in the US smoke cigarettes, and tobacco use is responsible for considerable morbidity and mortality in this group. Little is known about the efficacy of tobacco treatment strategies in PLWH.

designRandomized controlled trial comparing Positively Smoke Free (PSF), an intensive group-therapy intervention targeting HIV-infected smokers, to standard care.

methodsA cohort of 145 PLWH smokers, recruited from an HIV-care center in the Bronx, New York, were randomized 1:1 into the PSF program or standard care. All were offered a 3-month supply of nicotine replacement therapy. PSF is an 8-session program tailored to address the needs and concerns of HIV-infected smokers. The sessions were cofacilitated by a graduate student and an HIV-infected peer. The primary outcome was biochemically confirmed, 7-day point-prevalence abstinence at 3 months.

resultsIn the intention-to-treat analysis, PSF condition subjects had nearly double the quit rate of controls (19.2% vs. 9.7%, P = 0.11). In the complete case, as-treated analysis, assignment to PSF was associated with increased odds of quitting (odds ratio(adj) 3.55, 95% confidence interval 1.04 to 12.0). Latino ethnicity and lower loneliness score were predictive of abstinence. The subjects in the PSF condition exhibited significant decreases in daily cigarette consumption and significant increases in self-efficacy and in motivation to quit. Attendance of ≥7 sessions was associated with higher quit rates.

conclusionsThese findings suggest a positive effect of PSF on cessation rates in PLWH smokers. Loneliness and self-efficacy are influential factors in the smoking behaviors of PLWH.

Indexed as

AdultAgedFemaleHIV InfectionsHumansMaleMiddle AgedNew YorkSmokingSmoking CessationTreatment Outcome

Identifiers

PMID22732470
PMCPMC3568498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.